Oman

Oman joins ICH as 'observer'

 

Muscat: Oman, represented by the Drug Safety Centre at the Ministry of Health, has been granted 'observer' status in the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), marking a step forward in the country's pharmaceutical regulatory system and its international engagement in the health sector.

The ICH brings together regulatory authorities and the pharmaceutical industry from around the world to harmonise technical requirements for medicines and develop scientific guidelines and standards governing their quality, safety and efficacy.

The observer status will enable Oman to benefit from international expertise and experience, keep abreast of the latest regulatory and scientific developments, and strengthen national capacities in pharmaceutical regulation.

It will also support efforts to align the country's regulatory requirements with international guidelines, contributing to greater efficiency in the pharmaceutical oversight system.